Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 26, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Endogenous Engineering Reprograms Extracellular Vesicles for Enhanced Therapeutic Function.

Jinghui Wang1,2, Wenxuan Zhao2, Xiaoming Hu2

  • 1Department of Gastroenterology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|May 25, 2026
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathophysiology-driven neuroimaging: decoding brain injury in sepsis.

Frontiers in molecular neuroscience·2026
Same author

China's carbon emissions trading system (ETS) helps the country slow down industrial solid waste accumulation.

Journal of the Air & Waste Management Association (1995)·2026
Same author

Inorganic nanomaterials empowering bacteria: a new paradigm for biomedical applications.

Journal of materials chemistry. B·2026
Same author

Nano-micro Combination: Overcoming Dual Intranasal Barriers to Elicit a Comprehensive Immune Response.

ACS applied materials & interfaces·2026
Same author

Development of 1 month core-shell microspheres combination formulation containing teriparatide for osteoporosis treatment.

Biomaterials·2026
Same author

Engineering lipid nanoparticle-stabilized emulsions for spatiotemporal mRNA delivery and enhanced T cell immunity.

Cell reports. Medicine·2026
Same journal

Learning Moisture-Induced Damage From Vision: Diffusion Models for Real-Time Monitoring of Additive Manufacturing Processes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Intrinsic Dual-Phase Regulated GeSe<sub>2</sub> Nanoparticles Triggered by Ball-Milling Treatment for Photonic Multi-Valued Logic Circuits.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Plant Photoregulator-Inspired S-Type Heterojunction System for Diabetic Keratopathy via Tri-Modal Light-Driven Immunometabolic Reprogramming, Tissue Repair, and Antibacterial Activity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

eEF1G Orchestrates Translation to Ensure Meiotic Progression in Transcriptionally Quiescent Spermatocytes.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Ultrasound-Recharged Sub-Nanometer Palladium Catalysts for on-Demand and Self-Terminating Bioorthogonal Prodrug Activation in Cancer Therapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Graphene Aerogels With Spherical Pore Structure for Broad Frequency Regulation and Enhanced Low-Frequency Response.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles
This summary is machine-generated.

Researchers are reprogramming cells to engineer extracellular vesicles (EVs) for targeted drug delivery. This involves modifying cells genetically and environmentally to load proteins and nucleic acids for treating diseases like cancer and cardiovascular conditions.

Area of Science:

  • Biotechnology
  • Cell Biology
  • Nanomedicine

Background:

  • Extracellular vesicles (EVs) are natural carriers of therapeutic molecules.
  • EV biogenesis pathways offer opportunities for cargo regulation.
  • Engineering EVs enhances their therapeutic potential.

Purpose of the Study:

  • To review strategies for reprogramming EV-producing cells to load functional proteins and nucleic acids.
  • To explore the combination of environmental cues and genetic programming for EV engineering.
  • To summarize therapeutic applications and future directions in EV-based therapeutics.

Main Methods:

  • Modulating cellular environments to influence EV cargo.
  • Genetic engineering of cells for protein and nucleic acid recruitment into EVs.
Keywords:
endogenous engineeringextracellular vesiclesnucleic acidprotein cargotherapeutic applications

More Related Videos

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

Related Experiment Videos

Last Updated: May 26, 2026

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

  • Utilizing intrinsic EV sorting machinery and engineered molecular interactions.
  • Leveraging RNA-binding proteins (RBPs) and sorting motifs for nucleic acid loading.

    • Main Results:

    • Demonstrated strategies for loading proteins via physiological stimuli and genetic systems (scaffold fusion, peptide tags).
    • Highlighted methods for enriching nucleic acids (miRNAs, mRNAs, RNP complexes) through environmental changes and targeted loading.
    • Summarized successful therapeutic applications in cardiovascular, hepatic, neurological diseases, and cancer.

    Conclusions:

    • Cellular reprogramming offers a powerful approach for engineering EVs with specific therapeutic cargos.
    • Combined environmental and genetic strategies enhance the efficiency and specificity of EV loading.
    • Further advancements in discovery, biomanufacturing, and standardization are crucial for clinical translation of EV therapeutics.